ARISTOCORT Drug Patent Profile

« Back to Dashboard

When do Aristocort patents expire, and when can generic versions of Aristocort launch?

Aristocort is a drug marketed by Astellas and Fosun Pharma and is included in fourteen NDAs.

The generic ingredient in ARISTOCORT is triamcinolone. Additional details are available on the triamcinolone profile page.

Summary for ARISTOCORT

US Patents:	0
Applicants:	2
NDAs:	14

US Patents and Regulatory Information for ARISTOCORT

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Astellas	ARISTOCORT	triamcinolone acetonide	CREAM;TOPICAL	083017-003	Approved Prior to Jan 1, 1982		DISCN	No	No
Astellas	ARISTOCORT A	triamcinolone acetonide	CREAM;TOPICAL	083015-003	Approved Prior to Jan 1, 1982		DISCN	No	No
Astellas	ARISTOCORT	triamcinolone acetonide	OINTMENT;TOPICAL	080745-002	Approved Prior to Jan 1, 1982		DISCN	Yes	No
Fosun Pharma	ARISTOCORT	triamcinolone diacetate	INJECTABLE;INJECTION	011685-003	Approved Prior to Jan 1, 1982		DISCN	No	No
Astellas	ARISTOCORT	triamcinolone	TABLET;ORAL	011161-011	Approved Prior to Jan 1, 1982		DISCN	No	No
Astellas	ARISTOCORT A	triamcinolone acetonide	OINTMENT;TOPICAL	080750-003	Approved Prior to Jan 1, 1982		DISCN	No	No
Astellas	ARISTOCORT	triamcinolone diacetate	SYRUP;ORAL	011960-004	Approved Prior to Jan 1, 1982		DISCN	No	No